James Scopa - Jun 7, 2022 Form 4 Insider Report for DICE Therapeutics, Inc. (DICE)

Role
Director
Signature
/s/ Scott Robertson as attorney-in-fact for James P. Scopa
Stock symbol
DICE
Transactions as of
Jun 7, 2022
Transactions value $
$0
Form type
4
Date filed
6/8/2022, 04:53 PM
Previous filing
Feb 11, 2022
Next filing
Jun 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (right to buy Common Stock) Award $0 +21.3K $0.00 21.3K Jun 7, 2022 Common Stock 21.3K $14.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier to occur of: (i) the one-year anniversary of the grant date and (ii) the subsequent annual meeting of the Registrant's stockholders, in each case, subject to the Reporting Holder's continued service to the Registrant.